Daily English Article — June 17, 2026

A major new study has found that updated COVID-19 vaccines continue to provide meaningful protection against serious cardiovascular events, even as the virus has evolved and population immunity has grown. Published in JAMA Internal Medicine, the research drew on data from over one million patients in the US Department of Veterans Affairs health system, making it one of the largest analyses of its kind to examine the heart-related benefits of the most recent COVID-19 shots.

The study compared patients who received both the 2024–2025 COVID-19 vaccine and a seasonal flu shot against those who received only the flu shot, which served as the control group. Researchers tracked major adverse cardiovascular events, known as MACE, over eight months. These events included cardiovascular death, heart attack, stroke, and hospitalization for heart failure. The overall vaccine effectiveness against COVID-19-associated MACE was found to be 38 percent.

In absolute terms, the protective benefit is modest but clinically meaningful. The COVID-19 vaccine reduced the rate of associated MACE events from approximately 5 in 10,000 patients to 3 in 10,000. The benefits were most pronounced among people aged 75 and older and those with pre-existing medical conditions. This suggests the vaccine continues to deliver its strongest protection to those who are most medically vulnerable and at greatest risk of severe outcomes.

The researchers, led by epidemiologist Ziyad Al-Aly, also examined MACE and deaths in cases where COVID-19 infection had not been formally documented. The protective effect appeared even greater in this group, suggesting that many COVID-19 infections went undetected. Extrapolating their findings to a hypothetical population of one million people, the team estimated that vaccination could plausibly prevent around 2,370 MACE events and 1,580 deaths over an eight-month period.

The study does carry notable limitations. The VA patient population is predominantly older, White, and male, which means the findings may not fully generalize to the broader US population. Nevertheless, the results reinforce the case that COVID-19 vaccines continue to offer meaningful cardiovascular protection, a benefit that scientists say should inform individual decisions about whether to receive the updated seasonal shots, particularly for high-risk groups.

Apple has revealed the reasons behind the lengthy development process for the dramatically upgraded Siri featured in iOS 27. Speaking at a media tech talk held shortly after the company's annual WWDC keynote, Mike Rockwell, who assumed leadership of the Siri team just last year, explained that the delays were the result of a deliberate and far-reaching decision to abandon an earlier incremental approach and rebuild the assistant entirely from the ground up.

Rockwell disclosed that Apple had initially developed a first version of the upgraded Siri that added tool-calling capabilities on top of the original assistant's existing architecture. While that version was functional, the team concluded it fell short of the experience Apple wanted to deliver. Facing a choice between a modest upgrade and a more ambitious redesign, Apple chose the latter, committing to a complete architectural overhaul rather than settling for an incremental improvement that would have reached users sooner.

The decision to rebuild Siri from scratch resulted in a fundamentally different product. The new Siri is described as natively multimodal, meaning it can process and respond to multiple types of input simultaneously, such as text, images, and voice. Privacy was also built into the system from its foundations rather than added as an afterthought. Rockwell emphasized that Apple's powerful in-house AI models made this kind of transformative rebuild possible and allowed the team to realize a much more ambitious vision.

A key priority for the new Siri was achieving a consistent and unified experience across all of Apple's major platforms. Unlike previous versions that could behave differently depending on the device, the rebuilt Siri operates identically on iPhone, iPad, Mac, Apple Watch, Vision Pro, CarPlay, and AirPods. This cross-platform consistency was described as critically important to the team, as it ensures users encounter the same capabilities and behavior regardless of which Apple device they are using.

Apple's willingness to delay a product in order to deliver a more complete and coherent experience reflects a pattern the company has followed at various points in its history. While the extended timeline frustrated users who had anticipated AI improvements in earlier iOS releases, Rockwell's explanation suggests the trade-off may prove worthwhile. The rebuilt Siri represents a significant architectural leap, and Apple appears confident that the deeper foundation will support more powerful capabilities in the years ahead.